Rol' giperaktivnosti simpaticheskoy nervnoy sistemy v razvitii serdechno-sosudistykh zabolevaniy i vozmozhnosti farmakologicheskoy korrektsii
- Authors: Dorofeeva GB1, Dorofeev VI1, Trofimova Y.V1
-
Affiliations:
- Issue: Vol 9, No 1 (2012)
- Pages: 18-23
- Section: Articles
- URL: https://journals.eco-vector.com/2075-082X/article/view/33136
- DOI: https://doi.org/10.26442/SG33136
- ID: 33136
Cite item
Full Text
Abstract
References
- Агеев Ф.Т., Даниелян М.О., Мареев В.Ю. и др. Сердечная недостаточность. 2004; 5 (1): 4-7.
- Goldberg RJ, Larson M, Levy D. Factors associated with survival to 75 years of age in middle- aged men and women. Arch Intern Med 1996; 156: 505-10.
- Ng AV, Callister R, Johnson DG, Seals DR. Age and gender influence muscle sympathetic nerve activity at rest in healthy humans. Hypertension 1993; 21: 498-503.
- Furberg CD, Psaty BM, Meyer JV. Nifedipine. Dose-related increase in mortality in patients with coronary heart disease. Circulation 1995; 91: 1326-31.
- Kannel WB. Office assessment of coronary candidates and risk factor insights from the Framingham study. J Hypertension 1991; 9 (Suppl.): 13-9.
- Kaplan JR, Pettersson K, Manuk SB, Olsson G. Role of sympathoadrenal 1-medullary activation in the initiation and progression of atherosclerosis. Circulation 1991; 84 (Suppl. 6): V123-V132.
- Pauletto P, Scannapieco G, Pessina AC. Sympathetic drive and vascular damage in hyper tension and atherosclerosis. Hypertension 1991; 17 (Suppl. III): III75-III81.
- Bonora E, Kiechl S, Oberhollenzer F et al. Impaired glucose toler ance, Type II diabetes mellitus and carotid atherosclerosis: prospective results from the Bruneck Study. Diabetologia 2000; 43: 156-64.
- Pyorala M, Miettinen H, Halonen P et al. Insulin resistance syndrome predicts the risk of coronary heart disease and stroke in healthy mid dle-aged men. Arterioscler Thromb Vase Biol 2000; 20: 538-44.
- Ernsberger P, Koletsky RJ, Friedman JE. Contribution of sympathetic nervous system overactivity to cardiovascular and metabolic disease. Rev Contemp Pharmacother 1998; 9: 411-28.
- Мкртчян В.В. Нарушения ритма. Диабет. Образ жизни. 2002; 4: 3-5.
- Корнева К.Г., Панов Е.И. Особенности аритмий сердца у больных сахарным диабетом 2-го типа. Клинич. мед. 2006; 7: 21-4.
- Кан Ж.И. Состояние левых отделов сердца у больных сахарным диабетом 2 типа в сочетании с артериальной гипертензией. Автореф. дис. ... канд. мед. наук.
- Онучина Е.Л. и др. Нарушения ритма сердца у пациентов с сахарным диабетом 2 типа. Кардиология. 2008; 1: 25-7.
- European Sociery of Hypertension - European Sociery of Cardiology guidelmes for the management of arterial hypertension. J Hypertens 2003; 21: 1011-53.
- Aronow WS. Epidemiology, pathophysiology, prognosis and treatment of systolic heart failure in elderly patients. Heart Dis 2003; 5: 279-94.
- Bristow MR. Beta-adrenergic receptor blocade in chronic heart failure. Circulation 2000. 101: 558-69.
- Cohn JN. Beta-blockers in heart failure. Eur Heart J 1998; 19: F 52-5.
- CIBIS II Investigators and Committies. The Cardiak Inswufficiency Bisoprolol Study II (CIBIS II): a randomised trial. Lancet 1999; 353: 9-13.